Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Equivalent Dose of Alfentanil and Sufentanil Combined With Remimazolam in Complex Bronchoscopic Treatment

NCT06414018 is registered in ClinicalTrials.gov with Tongji Hospital as lead sponsor.

NCT NCT06414018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06414018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Equivalent Dose of Alfentanil and Sufentanil Combined With Remimazolam in Complex Bronchoscopic Treatment
Lead sponsor
Tongji Hospital
Phase
Not applicable
Overall status
Completed
Start date
May 20, 2024
Completion date
December 28, 2024
Enrollment
80 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

effect of drug